US Stock MarketDetailed Quotes

HSDT Helius Medical Technologies

Watchlist

4.5000
+0.0600+1.35%

Close Apr 26 16:00 ET

3.99MMarket Cap-309P/E (TTM)

Helius Medical Technologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

27.21%-10.42M

5.09%-2.03M

35.83%-2.45M

25.22%-2.74M

31.87%-3.19M

-6.89%-14.31M

38.12%-2.14M

-18.11%-3.82M

2.79%-3.66M

-60.29%-4.68M

Net income from continuing operations

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

78.02%-1.03M

36.30%-3.81M

-29.27%-4.35M

Operating gains losses

-42.57%-3.25M

-149.11%-1.13M

112.14%576K

-492.06%-1.48M

-460.37%-1.22M

-32,485.71%-2.28M

12,010.53%2.3M

-1,696.97%-4.74M

297.91%378K

-64.39%-217K

Depreciation and amortization

-36.47%162K

-47.50%21K

-40.85%42K

-33.33%48K

-29.17%51K

-18.27%255K

-46.67%40K

-5.33%71K

-6.49%72K

-15.29%72K

Other non cash items

-38.82%52K

7.69%14K

8.33%13K

-51.85%13K

-63.64%12K

3.66%85K

-63.89%13K

-25.00%12K

80.00%27K

120.00%33K

Change In working capital

76.19%-311K

-336.07%-288K

107.29%24K

79.07%-99K

108.31%52K

-1,128.35%-1.31M

-21.79%122K

-199.10%-329K

-48.74%-473K

-1,355.81%-626K

-Change in receivables

-182.52%-291K

-313.11%-504K

267.65%57K

-147.62%-20K

1,500.00%176K

-10,400.00%-103K

-144.00%-122K

-213.33%-34K

347.06%42K

-71.05%11K

-Change in inventory

223.42%137K

607.14%71K

245.45%48K

342.11%46K

37.78%-28K

-27.59%-111K

-122.58%-14K

-6.45%-33K

17.39%-19K

52.63%-45K

-Change in prepaid assets

115.25%54K

47.56%-269K

-92.06%25K

345.59%167K

248.86%131K

-178.74%-354K

-755.00%-513K

916.13%315K

-25.93%-68K

-100.00%-88K

-Change in payables and accrued expense

78.42%-123K

-44.06%438K

85.54%-82K

35.42%-268K

43.13%-211K

-201.24%-570K

136.56%783K

-253.66%-567K

-96.68%-415K

-601.35%-371K

-Change in other current liabilities

-20.45%-53K

0.00%-13K

-16.67%-14K

0.00%-13K

-116.67%-13K

30.16%-44K

18.75%-13K

25.00%-12K

18.75%-13K

60.00%-6K

-Change in other working capital

71.77%-35K

-1,200.00%-11K

-600.00%-10K

---11K

97.64%-3K

22.50%-124K

100.90%1K

103.92%2K

--0

-12,600.00%-127K

Cash from discontinued investing activities

Operating cash flow

27.21%-10.42M

5.09%-2.03M

35.83%-2.45M

25.22%-2.74M

31.87%-3.19M

-6.89%-14.31M

38.12%-2.14M

-18.11%-3.82M

2.79%-3.66M

-60.29%-4.68M

Investing cash flow

Cash flow from continuing investing activities

-163.64%-29K

-250.00%-3K

14.29%-6K

90.00%-1K

-575.00%-19K

80.36%-11K

140.00%2K

76.67%-7K

-10K

119.05%4K

Net PPE purchase and sale

-163.64%-29K

-250.00%-3K

14.29%-6K

90.00%-1K

-575.00%-19K

79.63%-11K

140.00%2K

76.67%-7K

---10K

121.05%4K

Cash from discontinued investing activities

Investing cash flow

-163.64%-29K

-250.00%-3K

14.29%-6K

90.00%-1K

-575.00%-19K

80.36%-11K

140.00%2K

76.67%-7K

---10K

119.05%4K

Financing cash flow

Cash flow from continuing financing activities

-93.97%1.08M

622K

-97.36%455K

-15.42%17.87M

3,223.51%17.25M

442.47%637K

-100.15%-17K

Net common stock issuance

-97.32%500K

--216K

-98.42%284K

----

-17.85%18.64M

--0

3,019.58%18M

----

Proceeds from stock option exercised by employees

--642K

--435K

----

--0

----

Net other financing activities

91.61%-65K

---29K

----

73.17%-775K

--0

-1,194.83%-751K

96.35%-7K

98.72%-17K

Cash from discontinued financing activities

Financing cash flow

-93.97%1.08M

--622K

-97.36%455K

--0

-15.42%17.87M

--0

3,223.51%17.25M

442.47%637K

-100.15%-17K

Net cash flow

Beginning cash position

32.20%14.55M

-60.47%6.6M

162.73%8.6M

79.71%11.34M

32.20%14.55M

230.38%11.01M

255.06%16.69M

-55.92%3.27M

-44.63%6.31M

230.38%11.01M

Current changes in cash

-364.04%-9.37M

33.91%-1.42M

-114.92%-2M

9.75%-2.74M

31.65%-3.21M

-53.81%3.55M

-133.96%-2.14M

588.75%13.42M

23.21%-3.04M

-158.12%-4.7M

Effect of exchange rate changes

125.00%1K

-50.00%1K

--0

50.00%-4K

--2K

-128.57%-6K

--0

End cash Position

-64.38%5.18M

-60.47%6.6M

162.73%8.6M

79.71%11.34M

32.20%14.55M

255.06%16.69M

-55.92%3.27M

-44.63%6.31M

Free cash flow

27.10%-10.45M

4.86%-2.04M

35.79%-2.46M

25.39%-2.74M

31.49%-3.21M

-6.57%-14.33M

38.26%-2.14M

-17.24%-3.83M

2.52%-3.67M

-59.21%-4.68M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	27.21%-10.42M	5.09%-2.03M	35.83%-2.45M	25.22%-2.74M	31.87%-3.19M	-6.89%-14.31M	38.12%-2.14M	-18.11%-3.82M	2.79%-3.66M	-60.29%-4.68M
Net income from continuing operations	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M	78.02%-1.03M	36.30%-3.81M	-29.27%-4.35M
Operating gains losses	-42.57%-3.25M	-149.11%-1.13M	112.14%576K	-492.06%-1.48M	-460.37%-1.22M	-32,485.71%-2.28M	12,010.53%2.3M	-1,696.97%-4.74M	297.91%378K	-64.39%-217K
Depreciation and amortization	-36.47%162K	-47.50%21K	-40.85%42K	-33.33%48K	-29.17%51K	-18.27%255K	-46.67%40K	-5.33%71K	-6.49%72K	-15.29%72K
Other non cash items	-38.82%52K	7.69%14K	8.33%13K	-51.85%13K	-63.64%12K	3.66%85K	-63.89%13K	-25.00%12K	80.00%27K	120.00%33K
Change In working capital	76.19%-311K	-336.07%-288K	107.29%24K	79.07%-99K	108.31%52K	-1,128.35%-1.31M	-21.79%122K	-199.10%-329K	-48.74%-473K	-1,355.81%-626K
-Change in receivables	-182.52%-291K	-313.11%-504K	267.65%57K	-147.62%-20K	1,500.00%176K	-10,400.00%-103K	-144.00%-122K	-213.33%-34K	347.06%42K	-71.05%11K
-Change in inventory	223.42%137K	607.14%71K	245.45%48K	342.11%46K	37.78%-28K	-27.59%-111K	-122.58%-14K	-6.45%-33K	17.39%-19K	52.63%-45K
-Change in prepaid assets	115.25%54K	47.56%-269K	-92.06%25K	345.59%167K	248.86%131K	-178.74%-354K	-755.00%-513K	916.13%315K	-25.93%-68K	-100.00%-88K
-Change in payables and accrued expense	78.42%-123K	-44.06%438K	85.54%-82K	35.42%-268K	43.13%-211K	-201.24%-570K	136.56%783K	-253.66%-567K	-96.68%-415K	-601.35%-371K
-Change in other current liabilities	-20.45%-53K	0.00%-13K	-16.67%-14K	0.00%-13K	-116.67%-13K	30.16%-44K	18.75%-13K	25.00%-12K	18.75%-13K	60.00%-6K
-Change in other working capital	71.77%-35K	-1,200.00%-11K	-600.00%-10K	---11K	97.64%-3K	22.50%-124K	100.90%1K	103.92%2K	--0	-12,600.00%-127K
Cash from discontinued investing activities
Operating cash flow	27.21%-10.42M	5.09%-2.03M	35.83%-2.45M	25.22%-2.74M	31.87%-3.19M	-6.89%-14.31M	38.12%-2.14M	-18.11%-3.82M	2.79%-3.66M	-60.29%-4.68M
Investing cash flow
Cash flow from continuing investing activities	-163.64%-29K	-250.00%-3K	14.29%-6K	90.00%-1K	-575.00%-19K	80.36%-11K	140.00%2K	76.67%-7K	-10K	119.05%4K
Net PPE purchase and sale	-163.64%-29K	-250.00%-3K	14.29%-6K	90.00%-1K	-575.00%-19K	79.63%-11K	140.00%2K	76.67%-7K	---10K	121.05%4K
Cash from discontinued investing activities
Investing cash flow	-163.64%-29K	-250.00%-3K	14.29%-6K	90.00%-1K	-575.00%-19K	80.36%-11K	140.00%2K	76.67%-7K	---10K	119.05%4K
Financing cash flow
Cash flow from continuing financing activities	-93.97%1.08M	622K	-97.36%455K	0	0	-15.42%17.87M	0	3,223.51%17.25M	442.47%637K	-100.15%-17K
Net common stock issuance	-97.32%500K	--216K	-98.42%284K	----	----	-17.85%18.64M	--0	3,019.58%18M	----	----
Proceeds from stock option exercised by employees	--642K	--435K	----	----	----	--0	--0	----	----	----
Net other financing activities	91.61%-65K	---29K	----	----	----	73.17%-775K	--0	-1,194.83%-751K	96.35%-7K	98.72%-17K
Cash from discontinued financing activities
Financing cash flow	-93.97%1.08M	--622K	-97.36%455K	--0	--0	-15.42%17.87M	--0	3,223.51%17.25M	442.47%637K	-100.15%-17K
Net cash flow
Beginning cash position	32.20%14.55M	-60.47%6.6M	162.73%8.6M	79.71%11.34M	32.20%14.55M	230.38%11.01M	255.06%16.69M	-55.92%3.27M	-44.63%6.31M	230.38%11.01M
Current changes in cash	-364.04%-9.37M	33.91%-1.42M	-114.92%-2M	9.75%-2.74M	31.65%-3.21M	-53.81%3.55M	-133.96%-2.14M	588.75%13.42M	23.21%-3.04M	-158.12%-4.7M
Effect of exchange rate changes	125.00%1K	-50.00%1K	--0	--0	--0	50.00%-4K	--2K	-128.57%-6K	--0	--0
End cash Position	-64.38%5.18M	-64.38%5.18M	-60.47%6.6M	162.73%8.6M	79.71%11.34M	32.20%14.55M	32.20%14.55M	255.06%16.69M	-55.92%3.27M	-44.63%6.31M
Free cash flow	27.10%-10.45M	4.86%-2.04M	35.79%-2.46M	25.39%-2.74M	31.49%-3.21M	-6.57%-14.33M	38.26%-2.14M	-17.24%-3.83M	2.52%-3.67M	-59.21%-4.68M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall